REGULATORY INTELLIGENCE·Recall
Blossom Pharmaceuticals Initiates Class II Recall of Dynashield Skin Protectant Over cGMP Deviations in India
Blossom Pharmaceuticals has initiated a Class II recall of 1,560 units of Dynashield Skin Protectant (Zinc Oxide) due to cGMP deviations at its Bardej, Goa, India facility. This impacts Dynarex Corporation and US nationwide distribution, signaling critical supply chain and regulatory risks for procurement and regulatory affairs teams.
90-Day Activity